MedPath

Dietary Supplements and Aging Muscle

Not Applicable
Completed
Conditions
Sarcopenia
Registration Number
NCT01057082
Lead Sponsor
University of Alabama at Birmingham
Brief Summary

The purpose of this study is to determine whether older adults (ages 65-89) who consume the dietary supplement Juven (Abbott Laboratories) versus placebo for 6 months will demonstrate increases in fat-free mass, muscle volume,and physical function.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
36
Inclusion Criteria
  • Ages 65-89
  • Ambulatory
Exclusion Criteria
  • Cognitive impairment
  • History of renal or hepatic disease
  • History of hypotension
  • History of peripheral artery disease
  • Uncontrolled hypertension
  • Uncontrolled diabetes
  • Self-reported claustrophobia
  • Current smoker
  • Steroid or androgen use with the previous 3 months
  • Individuals with pacemakers and defibrillators

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Fat-free mass as determined by a four-compartment model of body compositionBaseline, 3-months, 6-months
Secondary Outcome Measures
NameTimeMethod
Appendicular lean mass as determined by dual energy X-ray absorptiometryBaseline, 3-months, 6-months
Muscle volume as determined by magnetic resonance imagingBaseline and 6-months
Physical function as determined by questionnaire and a battery of physical performance testsBaseline and 6 months

Trial Locations

Locations (1)

University of Alabama at Birmingham

🇺🇸

Birmingham, Alabama, United States

University of Alabama at Birmingham
🇺🇸Birmingham, Alabama, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.